Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
2021 · British Journal of Haematology · 42 citations
https://doi.org/10.1111/bjh.17654
A
Agnès Guerci
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
4.6K
Citations
27
h-index
46
i10-index
Agnès Guerci is an academic researcher from Centre Hospitalier Régional et Universitaire de Nancy. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research. The author has an h-index of 27, co-authored 80 publications.
Papers by this author
worksLong-Term Follow-up of the French 1 Stop Imatinib Study (STIM1) in Chronic Myeloid Leukemia Patients
2015 · Blood · 16 citations
https://doi.org/10.1182/blood.v126.23.345.345
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
2024 · Leukemia · 6 citations
https://doi.org/10.1038/s41375-024-02180-3
Aberrant DNA Methylation is association with differential gene expression in immature cells CD34+ CD15- from patients with primary Chronic Myeloid Leukemia
2019 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Traitement de première ligne de la Leucémie Myéloïde Chronique dans la « vraie vie » : Données de l’Observatoire LMC
2019 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat